Evaluation and Treatment of Pericarditis: A Systematic Review: This systematic review summarizes published evidence on the causes, diagnosis, therapy, prevention, and prognosis of pericarditis. Massimo Imazio. Fiorenzo Gaita. Martin LeWinter. JAMA.
Source: jamanetwork.com
Another child with cancer endangered by alternative medicine: Yesterday, I wrote about the winner of the Nobel Prize in Physiology or Medicine, Youyou Tu, who, after screening 2,000 herbal treatments from traditional Chinese medicine (TCM) for anti-malaria activity, finally discovered Artemisinin. She...
Source: scienceblogs.com
Researchers design 'biological flashlight' using light-producing ability of shrimp: Using the natural light-producing ability of deep-sea shrimp, a UNC Lineberger Comprehensive Cancer Center researcher and a team of scientists developed a new imaging tool to help cancer researchers better track tumor...
Source: medicalxpress.com
WHO | Treat all people living with HIV, offer antiretrovirals as additional prevention choice for people at "substantial" risk: 30 September 2015 -- With its "treat-all" recommendation, WHO removes all limitations on eligibility for antiretroviral therapy (ART) among people living with HIV; all populations...
Source: who.int
Study's message to recovering alcoholics: Quit smoking to stay sober: Adult smokers with a history of problem drinking who continue smoking are at a greater risk of relapsing three years later compared with adults who do not smoke. While treatments for alcohol abuse traditionally require concurrent treatment...
Source: eurekalert.org
Sanofi wins EU approval for Praluent anti-cholesterol drug: French drugmaker Sanofi said the European Commission had cleared its key cholesterol drug Praluent for the treatment of so-called "bad cholesterol," or low-density lipoprotein (LDL) cholesterol, in certain adult patients with hypercholesterolemia.
Source: reuters.com
FDA Approves Two New Treatments for Diabetes NEJM Journal Watch.
Source: jwatch.org
Gliptins and Cardiovascular Outcomes: A Comparative and Critical Analysis after TECOS: The issue related to macrovascular outcomes and intensive glycemic control was hotly debated after the publication of landmark trials like ACCORD, ADVANCE, and VADT. The only benefits seem to come from intervening...
Source: hindawi.com